New reserach has identified particular genetic mutations that elevate the risk of breast and ovarian cancers, aiding in ...

As the need to draw awareness to cervical, ovarian, uterine/endometrial, vaginal, and vulvar cancer becomes more evident, ...

From model Bianca Balti’s ovarian cancer diagnosis to hockey pro’s testicular cancer diagnosis, here’s what’s happening in ...

Dr. Diego Aviles with UT Physicians says symptoms of ovarian cancer typically include bloating, pain in the stomach or pelvis ...

Mirvetuximab soravtansine was the first ADC to show efficacy as a therapy for platinum-resistant ovarian cancer. Despite high ...

Researchers developed a pan-immune-inflammation–based nomogram to accurately predict overall survival (OS) and ...

Adding a PD-1 inhibitor to PARP inhibitor maintenance therapy failed to slow progression or improve survival in newly ...

1 in 75 women develop ovarian cancer in their lifetime and Everyone with ovaries is at risk ...

Johnson & Johnson (JNJ) announced that its subsidiary, Red River Talc LLC, has voluntarily filed for a prepackaged Chapter 11 ...

Elahere was found to improve survival in patients with FR-alpha–positive, platinum-resistant, high-grade serous epithelial ...

Elahere, which won initial U.S. Food and Drug Administration approval in 2022 for platinum-resistant ovarian cancer, was the key asset in AbbVie's $10.1 billion acquisition of biotech ImmunoGen that ...